Answers are grounded in this paper and cite their sources.
Implementation study outlines multimodal clinical decision support for routine prescribing across seven European countries, indicating scalable strategies for genetic-guided healthcare.
Clinical pharmacogenomics (PGx) has the potential to make pharmacotherapy safer and more effective by utilizing genetic patient data for drug dosing and selection. However, widespread adoption of PGx depends on its successful integration into routine clinical care through clinical decision support tools, which is often hampered by insufficient or fragmented infrastructures. This paper describes the setup and implementation of a unique multimodal, multilingual clinical decision support intervention consisting of digital, paper-, and mobile-based tools that are deployed across implementation sites in seven European countries participating in the Ubiquitous PGx (U-PGx) project.
No takes yet. Share an insight, caveat, or question.
Blagec et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: